Evidence map›Paper›PMID 33658521›Full record

ArticleNature communications2021

Staphylococcus aureus induces an itaconate-dominated immunometabolic response that drives biofilm formation.

Kira L Tomlinson, Tania Wong Fok Lung, Felix Dach, Medini K Annavajhala, Stanislaw J Gabryszewski, Ryan A Groves, Marija Drikic, Nancy J Francoeur, Shwetha H Sridhar, Melissa L Smith and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 1 synthesis or guideline pooled it, 144 citations in OpenAlex.

  1. The evolving landscape ofFrontiers in immunology · 2026
    Pooled it
  2. Review
  3. Review
  4. Itaconate and its derivatives in human health and diseases.Signal transduction and targeted therapy · 2026
    Review
  5. Article
  6. bioRxiv : the preprint server for biology · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Role of itaconate in intestinal disease (Review).International journal of molecular medicine · 2026
    Review
  12. Itaconate modifications: Mechanisms and applications.Journal of intensive medicine · 2026
    Review
  13. Article
  14. Article
  15. T6SS mutants exploit itaconate to support infection of phagocytes.bioRxiv : the preprint server for biology · 2026
    Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Kira L Tomlinson *Department of Pediatrics, Columbia University, New York, NY, 10032, USA.ORCID 0000-0002-8730-276X
Tania Wong Fok Lung *Department of Pediatrics, Columbia University, New York, NY, 10032, USA.ORCID 0000-0002-9318-9572
Felix Dach *Department of Pediatrics, Columbia University, New York, NY, 10032, USA.ORCID 0000-0002-6945-9843
Medini K AnnavajhalaDepartment of Medicine, Columbia University, New York, NY, 10032, USA.ORCID 0000-0002-9229-8849
Stanislaw J GabryszewskiDepartment of Pediatrics, Columbia University, New York, NY, 10032, USA.
Ryan A GrovesDepartment of Biological Sciences, University of Calgary, Calgary, T2N 1N4, Canada.
Marija DrikicDepartment of Biological Sciences, University of Calgary, Calgary, T2N 1N4, Canada.
Nancy J FrancoeurDepartment of Genetics and Genomic Sciences, Mt. Sinai Icahn School of Medicine, New York, NY, 10029, USA.
Shwetha H SridharDepartment of Genetics and Genomic Sciences, Mt. Sinai Icahn School of Medicine, New York, NY, 10029, USA.
Melissa L SmithDepartment of Genetics and Genomic Sciences, Mt. Sinai Icahn School of Medicine, New York, NY, 10029, USA.
Sara KhanalSection of Pulmonary, Critical Care, and Sleep Medicine, Yale University School of Medicine, New Haven, CT, 06520, USA.
Clemente J BrittoSection of Pulmonary, Critical Care, and Sleep Medicine, Yale University School of Medicine, New Haven, CT, 06520, USA.
Robert SebraDepartment of Genetics and Genomic Sciences, Mt. Sinai Icahn School of Medicine, New York, NY, 10029, USA.
Ian LewisDepartment of Biological Sciences, University of Calgary, Calgary, T2N 1N4, Canada.ORCID 0000-0002-5753-499X
Anne-Catrin UhlemannDepartment of Medicine, Columbia University, New York, NY, 10032, USA.
Barbara C KahlInstitute of Medical Microbiology Münster, University Hospital, Münster, 48149, Germany.ORCID 0000-0001-5155-3383
Alice S PrinceDepartment of Pediatrics, Columbia University, New York, NY, 10032, USA.ORCID 0000-0002-7399-9295
Sebastián A RiquelmeDepartment of Pediatrics, Columbia University, New York, NY, 10032, USA. sr3302@cumc.columbia.edu.ORCID 0000-0002-8375-4320
Columbia University · USUniversity of Calgary · CAUniversity Hospital Münster · DEYale University · USColumbia University Irving Medical Center · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007367 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI REINER, STEVEN L · 1985 to 2021
$25.1M
Innate Immune Clearance of Host-Adapted Pulmonary PathogensR35HL135800 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PRINCE, ALICE S · 2017 to 2023
$5.9M
Becton Dickinson LSR II Analytical Flow CytometerS10RR027050 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLYNES, RAPHAEL A. · 2011 to 2011
$413k
The immunometabolite itaconate drives S. aureus lung infectionF30AI161801 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TOMLINSON, KIRA LEIGH · 2022 to 2024
$138k
NCATS NIH HHS UL1 TR001863NCATS NIH HHS UL1 TR001873NCRR NIH HHS S10 RR027050NHLBI NIH HHS R35 HL135800NIAID NIH HHS F30 AI161801NIGMS NIH HHS T32 GM007367
6 · The paper itself

Abstract

Staphylococcus aureus is a prominent human pathogen that readily adapts to host immune defenses. Here, we show that, in contrast to Gram-negative pathogens, S. aureus induces a distinct airway immunometabolic response dominated by the release of the electrophilic metabolite, itaconate. The itaconate synthetic enzyme, IRG1, is activated by host mitochondrial stress, which is induced by staphylococcal glycolysis. Itaconate inhibits S. aureus glycolysis and selects for strains that re-direct carbon flux to fuel extracellular polysaccharide (EPS) synthesis and biofilm formation. Itaconate-adapted strains, as illustrated by S. aureus isolates from chronic airway infection, exhibit decreased glycolytic activity, high EPS production, and proficient biofilm formation even before itaconate stimulation. S. aureus thus adapts to the itaconate-dominated immunometabolic response by producing biofilms, which are associated with chronic infection of the human airway.

Indexed as

AdultAnimalsBiofilmsBronchoalveolar Lavage FluidCarbohydrate MetabolismCystic FibrosisGene Expression Regulation, BacterialGlycolysisHost-Pathogen InteractionsHumansHydro-LyasesMiceMice, Inbred C57BLPseudomonas InfectionsReactive Oxygen SpeciesSputumAcod1 protein, mouseHydro-Lyasesitaconic acidReactive Oxygen SpeciesSuccinatesSuccinic Acid

Identifiers

PMID33658521
PMCPMC7930111
OpenAlexW3134015568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.